title: Recurrent in-frame insertion in C/EBPalpha TAD2 region is a polymorphism without prognostic value in AML.
authors.forename: V
authors.initials: V
authors.lastname: Biggio
authors.forename: A
authors.initials: A
authors.lastname: Renneville
authors.forename: O
authors.initials: O
authors.lastname: Nibourel
authors.forename: N
authors.initials: N
authors.lastname: Philippe
authors.forename: L
authors.initials: L
authors.lastname: Terriou
authors.forename: C
authors.initials: C
authors.lastname: Roumier
authors.forename: P
authors.initials: P
authors.lastname: Amouyel
authors.forename: D
authors.initials: D
authors.lastname: Cottel
authors.forename: S
authors.initials: S
authors.lastname: Castaigne
authors.forename: H
authors.initials: H
authors.lastname: Dombret
authors.forename: X
authors.initials: X
authors.lastname: Thomas
authors.forename: P
authors.initials: P
authors.lastname: Fenaux
authors.forename: C
authors.initials: C
authors.lastname: Preudhomme
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D022763:CCAAT-Enhancer-Binding Protein-alpha / Q000235:genetics*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D016254:Mutagenesis, Insertional; D009363:Neoplasm Proteins / Q000235:genetics*; D011110:Polymorphism, Genetic; D011379:Prognosis; D017434:Protein Structure, Tertiary; D012306:Risk; D016019:Survival Analysis
chemical_list: D022763:CCAAT-Enhancer-Binding Protein-alpha; D009363:Neoplasm Proteins